Healthcare DIVE June 23, 2021
Another healthcare venture promises to lower costs, this time through leveraging patient data on drug efficacy through a handful of large insurers.
Five Blue Cross Blue Shield Plans are joining forces to help launch a new venture with a lofty but familiar goal: to reduce the cost of prescription drugs.
The plans have invested in a new independent company, Evio, which will harness a trove of data to assess how well a drug works, and will ultimately try to align a drug’s cost with how well it performs.
The move is in step with the larger industry trends of moving toward a system that pays for the value of care instead of the volume of services provided. But some are...